TMO stock verdict - Avoid
TMO
Thermo Fisher Scientific Inc
AVOIDHealthcare
$568.26
Fundamentals below bar
$568.26
Heavy$197.67Buy$263.56Fair$329.45Exit$395.34
FUNDAMENTAL47
TECHNICAL72
TRUST SCORE
100High
confidence in this read — data completeness, earnings quality & coverage
Uptrend · EMA20 527.15 · EMA50 507.12 · EMA200 508.88 · RSI 70.8 · MACD above signal
PROS
- Price is in an uptrend — above key moving averages with positive momentum
CONS
- Trades above the model's exit level ($395.34) — overvalued on this framework
- Expensive on trailing earnings (P/E 30.6×)
- Revenue declined 0.2%/yr on average over the last 3 years
✳ Pros and cons are machine-generated from the latest fundamentals and technicals.
EARNINGS QUALITY · we check the accounting so you don't have to
✓Operating cash flow is 117% of net income — profit is backed by real cash
✓Low accruals — reported profit tracks the cash actually generated
✓Receivables growing in line with sales
SECTOR PEERS
Analysis as of 2026-07-27 · price live, fundamentals from latest filings
FAQ
Why is TMO rated Avoid?
TMO (Thermo Fisher Scientific Inc) is rated Avoid because the model combines fundamentals, price action, and earnings-quality checks. The current signal is Fundamentals below bar. Price is in an uptrend — above key moving averages with positive momentum
Is TMO overvalued right now?
TMO is trading at $568.26 versus an estimated fair value of $329.45. That puts the stock in avoid territory on this framework. Trades above the model's exit level ($395.34) — overvalued on this framework and Expensive on trailing earnings (P/E 30.6×)
What should I watch before acting on TMO?
Watch the trust score of 100, the earnings-quality checks, and any red flags. Trades above the model's exit level ($395.34) — overvalued on this framework and Expensive on trailing earnings (P/E 30.6×)